Cargando…
Resolvin E1 derived from eicosapentaenoic acid prevents hyperinsulinemia and hyperglycemia in a host genetic manner
Eicosapentaenoic acid (EPA) has garnered attention after the success of the REDUCE‐IT trial, which contradicted previous conclusions on EPA for cardiovascular disease risk. Here we first investigated EPA's preventative role on hyperglycemia and hyperinsulinemia. EPA ethyl esters prevented obesi...
Autores principales: | Pal, Anandita, Al‐Shaer, Abrar E., Guesdon, William, Torres, Maria J., Armstrong, Michael, Quinn, Kevin, Davis, Traci, Reisdorph, Nichole, Neufer, P. Darrell, Spangenburg, Espen E., Carroll, Ian, Bazinet, Richard P., Halade, Ganesh V., Clària, Joan, Shaikh, Saame Raza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497168/ https://www.ncbi.nlm.nih.gov/pubmed/32579292 http://dx.doi.org/10.1096/fj.202000830R |
Ejemplares similares
-
Resolvin E1-ChemR23 Axis Regulates the Hepatic Metabolic and Inflammatory Transcriptional Landscape in Obesity at the Whole Genome and Exon Level
por: Al-Shaer, Abrar E., et al.
Publicado: (2021) -
Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?
por: Pal, Anandita, et al.
Publicado: (2020) -
The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis
por: Avanoǧlu Güler, Aslıhan, et al.
Publicado: (2020) -
High Fat Diet-Induced Obesity Dysregulates Splenic B Cell Mitochondrial Activity
por: Pal, Anandita, et al.
Publicado: (2023) -
Targeted Expression of Catalase to Mitochondria Protects Against Ischemic Myopathy in High-Fat Diet–Fed Mice
por: Ryan, Terence E., et al.
Publicado: (2016)